04:44 PM EDT, 10/31/2025 (MT Newswires) -- Frank McCormick, Director, on October 29, 2025, sold 198,359 shares in Bridgebio Pharma ( BBIO ) for $13,206,528. Following the Form 4 filing with the SEC, McCormick has control over a total of 763,254 common shares of the company, with 83,275 shares held directly and 679,979 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1743881/000147083125000282/xslF345X05/wk-form4_1761943122.xml